Today will be good day for $TSVT (2Seventy Bio Inc.) :)
An update from 2seventy bio (TSVT) is now available.
2seventy bio, Inc. and Bristol Myers Squibb have announced the FDA approval of Abecma, a new treatment for adult patients with relapsed or refractory multiple myeloma who have previously undergone... Show More
.
Tue Oct 15 2024 13:50:32 GMT+0000 (Coordinated Universal Time)
